| Health / Medical Topics |
Claudiximab
A chimeric monoclonal antibody directed against the antigen GC182 with potential immunostimulatory and antineoplastic activities. Upon administration, claudiximab specifically binds to GC128, which may stimulate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against GC182-expressing tumor cells, resulting in decreased tumor cell proliferation. The CD20-like antigen GC182, a gastric differentiation protein, is often overexpressed on the cell surfaces of a variety of tumor cells, including gastric, pancreatic, esophageal cancer and non-small cell lung cancer (NSCLC) cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A genetic profile indicating low expression of cellular tight junction proteins, including E-cadherin, which is often associated with triple-negative breast cancer and…
Limping or lameness.
Clathrin heavy chain 2 (1640 aa, ~187 kDa) is encoded by the human CLTCL1 gene. This protein is involved in both the…
Clathrin heavy chain 1 (1675 aa, ~192 kDa) is encoded by the human CLTC gene. This protein plays a role in formation…
Fragment of rock.
A member of the same class at school.
